Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (Aβ1-40), which may potentially inhibit the fibril formation

被引:161
作者
Ji, SR [1 ]
Wu, Y [1 ]
Sui, SF [1 ]
机构
[1] Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane, Beijing 100084, Peoples R China
关键词
D O I
10.1074/jbc.M104146200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Amyloid peptide (Abeta), a normal constituent of neuronal and non-neuronal cells, has been proven to be the major component of extracellular plaque of Alzheimer's disease. Interactions between Abeta and neuronal membranes have been postulated to play an important role in the neuropathology of Alzheimer's disease. Here we show that Abeta is able to insert into lipid bilayer. The membrane insertion ability of Abeta is critically controlled by the ratio of cholesterol to phospholipids. In a low concentration of cholesterol Abeta prefers to stay in membrane surface region mainly in a beta-sheet structure. In contrast, as the ratio of cholesterol to phospholipids rises above 30 mol%, Abeta can insert spontaneously into lipid bilayer by its C terminus. During membrane insertion Abeta generates about 60% alpha-helix and removes almost all beta-sheet structure. Fibril formation experiments show that such membrane insertion can reduce fibril formation. Our findings reveal a possible pathway by which Abeta prevents itself from aggregation and fibril formation by membrane insertion.
引用
收藏
页码:6273 / 6279
页数:7
相关论文
共 56 条
  • [1] Ames B., 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
  • [2] GIANT MULTILEVEL CATION CHANNELS FORMED BY ALZHEIMER-DISEASE AMYLOID BETA-PROTEIN [A-BETA-P-(1-40)] IN BILAYER-MEMBRANES
    ARISPE, N
    POLLARD, HB
    ROJAS, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10573 - 10577
  • [3] Avdulov NA, 1997, J NEUROCHEM, V69, P1746
  • [4] BARROW CJ, 1991, SCIENCE, V253, P180
  • [5] Alpha-2 macroglobulin is genetically associated with Alzheimer disease
    Blacker, D
    Wilcox, MA
    Laird, NM
    Rodes, L
    Horvath, SM
    Go, RCP
    Perry, R
    Watson, B
    Bassett, SS
    McInnis, MG
    Albert, MS
    Hyman, BT
    Tanzi, RE
    [J]. NATURE GENETICS, 1998, 19 (04) : 357 - 360
  • [6] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [7] RAPID ISOLATION OF NEURO-BLASTOMA PLASMA-MEMBRANES ON PERCOLL GRADIENTS - CHARACTERIZATION AND LIPID-COMPOSITION
    CHAKRAVARTHY, BR
    SPENCE, MW
    CLARKE, JTR
    COOK, HW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 812 (01) : 223 - 233
  • [8] Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles
    ChooSmith, LP
    GarzonRodriguez, W
    Glabe, CG
    Surewicz, WK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) : 22987 - 22990
  • [9] Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease
    Christie, RH
    Chung, H
    Rebeck, GW
    Strickland, D
    Hyman, BT
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (04) : 491 - 498
  • [10] Solution structure of amyloid β-peptide(1-40) in a water-micelle environment.: Is the membrane-spanning domain where we think it is?
    Coles, M
    Bicknell, W
    Watson, AA
    Fairlie, DP
    Craik, DJ
    [J]. BIOCHEMISTRY, 1998, 37 (31) : 11064 - 11077